Nataša Tul
University of Ljubljana
15 Papers
110 Citations
Nataša Tul is an academic researcher from University of Ljubljana. The author has contributed to research in topics: Pregnancy & Cervical pessary. The author has an hindex of 8, co-authored 15 publications. Previous affiliations of Nataša Tul include Ljubljana University Medical Centre.
Chat about Author
Papers
A Randomized Trial of a Cervical Pessary to Prevent Preterm Singleton Birth
Kypros H. Nicolaides,Argyro Syngelaki,Liona C. Poon,Gemma Picciarelli,Nataša Tul,Aikaterini Zamprakou,Evdoxia Skyfta,Mauro Parra-Cordero,Ricardo Palma-Dias,Jesus Rodriguez Calvo +9 more
TL;DR: Among girls and women with singleton pregnancies who had a short cervix, a cervical pessary did not result in a lower rate of spontaneous early preterm delivery than the rate with expectant management.
181
Cervical pessary placement for prevention of preterm birth in unselected twin pregnancies: a randomized controlled trial
Kypros H. Nicolaides,Argyro Syngelaki,Liona C. Poon,Catalina De Paco Matallana,Walter Plasencia,Francisca S. Molina,Gemma Picciarelli,Nataša Tul,E. Celik,Tze Kin Lau,Roberto Conturso +10 more
TL;DR: In women with twin pregnancy, routine treatment with cervical pessary does not reduce the rate of spontaneous early preterm birth.
134
Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception.
Nataša Tul,Ziva Novak-Antolic +1 more
TL;DR: Increased screen‐positive rate was observed in the first‐trimester screening for trisomy 21 (T21) among women after assisted conception, and trends in serum marker levels after different modes of assisted conception were identified.
52
Serum PAPP-A levels at 10-14 weeks of gestation are altered in women after assisted conception
Nataša Tul,Ziva Novak-Antolic +1 more
TL;DR: The presence of multiple corpora lutea may be responsible for the changes in marker levels after different modes of assisted conception, and the screen-positive rate for trisomy 21 is not significantly increased in women after assisted conception.
50
Identifying occult maternal malignancies from 1.93 million pregnant women undergoing noninvasive prenatal screening tests
Xing Ji,Jia Li,Yonghua Huang,Pi-Lin Sung,Pi-Lin Sung,Yuying Yuan,Qiang Liu,Yan Chen,Jia Ju,Yafeng Zhou,Shujia Huang,Fang Chen,Yuan Han,Wen Yuan,Cheng Fan,Qiang Zhao,Haitao Wu,Suihua Feng,Weiqiang Liu,Zhihua Li,Jingsi Chen,Min Chen,Hong Yao,Li Zeng,Tao Ma,Shushu Fan,Jinman Zhang,Ka Yiu Yuen,So Hin Cheng,Irene Wing Shan Chik,Nien-Tzu Liu,Jianyu Zhu,Siyuan Lin,Jeremy Cao,Steve Tong,Zhiyuan Shan,Wenyan Li,Mohammad Reza Hekmat,Masoud Garshasbi,Javier Suela,Yaima Torres,Juan C. Cigudosa,F. J. Pérez Ruiz,Laura Lyman Rodriguez,Monica D. Garcia,Janez Bernik,Eva Traven,Uršula Reš,Nataša Tul,Ching-Fong Tseng,Depeng Zhao,Luming Sun,Qiong Pan,Li Shen,Mengyao Dai,Yuying Wang,Jian Wang,Huanming Yang,Ye Yin,Ye Yin,Tao Duan,Baosheng Zhu,Mahesh Choolani,Xin Jin,Xin Jin,Yingwei Chen,Mao Mao +66 more
TL;DR: The CDP algorithm can diagnose occult maternal malignancies with a reasonable PPV in multiple chromosomal aneuploidies–positive pregnant women in NIPS tests and can be further improved by incorporating findings for plasma tumor markers.
42